Should I get screened for prostate cancer? What you should know about the PSA test

Annual Report cover
Prostate Cancer Canada's PSA resource is now available.

"Should I get screened for prostate cancer? What you should know about the PSA test" is now available on our website for viewing, downloading and ordering for free in English and French.

This brochure answers commonly asked questions about the PSA test, used to screen for prostate cancer. It includes information about who is at risk for prostate cancer, how testing works, the advantages and disadvantages of the test and what the results can mean. It has been designed for men who have questions about PSA testing and for physicians to use with, or distribute to, their patients.


Download a copy today (PDF, 2.29 MB)

Order a free copy today

Prostate Cancer Awareness Month

Donate Now!


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More


Click here for news archive